Category: Regulatory/FDA

05/23/2014

OPDP Enforcement Letters Address Omission of Risk Information

05/19/2014

WLF: FDA’s Revised Reprint Draft Guidance Violates Injunction and First Amendment

05/09/2014

FTC Cites Privacy Concerns Related to Mobile Health Apps

04/28/2014

FDA Willing to “Re-examine” Off-label Policies in Light of First Amendment Rulings

04/09/2014

CHC Press Release: Comment on Social Media Draft Guidance

04/07/2014

Some States Impose Reporting Requirements That Add to Sunshine Burden

03/31/2014

Kamp to WSJ: FDA Could Do a Better Job of Defending Off-label Limits

03/14/2014

OPDP Issues First Untitled Letter for Branded Facebook Page

03/10/2014

Cuts in Speaker Payments Should Be Placed in Proper Context